Bioelectronics Validation in Healthy Subjects
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test the safety and functionality of new wearable sensors that track health data. Participants will use these sensors, called the Multi-modality Noninvasive Biosensor, either before and after a short walk or continuously for two hours. The trial seeks healthy individuals without skin issues or adhesive allergies. It suits those who can perform daily activities and exercise without difficulty. As an unphased trial, this study allows participants to contribute to the development of innovative health technology.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on healthy individuals without significant illnesses, so it's best to ask the study team for clarification.
What prior data suggests that this biosensor is safe for wearability?
Research has shown that wearable biosensors are generally safe for use. These devices have been employed for medical tests and health tracking for some time. Studies have found that users usually tolerate them well, and those who have used similar devices have not reported major side effects.
This trial focuses on the comfort and effectiveness of the sensors. They are designed to function without causing harm or discomfort. Current research reports no harmful side effects, suggesting that the sensors are likely safe for both short and long-term wear.12345Why are researchers excited about this trial?
Researchers are excited about the Multi-modality Noninvasive Biosensor because it offers a new way to monitor health using advanced bioelectronic sensors. Unlike traditional methods that might involve invasive procedures or bulky equipment, this biosensor can be worn comfortably and noninvasively, either for short periods before and after exercise or continuously for two hours. This innovative approach could provide real-time health data with greater ease and comfort for users, potentially enhancing our understanding of physiological responses to physical activity. Overall, this trial could pave the way for more accessible, wearable health monitoring technology.
What evidence suggests that this biosensor is effective for wearability and function?
Research has shown that new noninvasive health sensors, like those studied in this trial, improve health monitoring. Participants will join different trial arms to evaluate the comfort and basic functions of these sensors. These devices gather detailed health information by analyzing sweat and other factors without piercing the skin. Recent advancements indicate increased accuracy through various detection methods. Machine learning enhances the sensors' ability to interpret collected data. While this study primarily examines the sensors' comfort and basic functions, the technology holds promise for noninvasive health tracking.46789
Who Is on the Research Team?
Wubin Bai, PhD
Principal Investigator
Assistant Professor of Applied Physical Sciences
Are You a Good Fit for This Trial?
This trial is for healthy men and women aged between 18 and 65 who don't have any significant illnesses. It's not suitable for those unable to do daily activities normally, with active skin disorders, allergies to silicones or adhesives, or damaged skin near where sensors would be placed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants wear the bioelectronic sensors and approved medical devices during a lab visit, either before and after exercise or for an extended period
Follow-up
Participants return to the lab for two brief visits to monitor for any adverse events related to the devices
What Are the Treatments Tested in This Trial?
Interventions
- Multi-modality Noninvasive Biosensor
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
North Carolina Translational and Clinical Sciences Institute
Collaborator